healius - PHCRF

PHCRF

Close Chg Chg %
0.97 -0.13 -13.40%

Closed Market

0.84

-0.13 (13.40%)

Volume: 950.00

Last Updated:

Apr 22, 2025, 12:11 PM EDT

Company Overview: healius - PHCRF

PHCRF Key Data

Open

$0.84

Day Range

0.84 - 0.84

52 Week Range

N/A - N/A

Market Cap

N/A

Shares Outstanding

726.13M

Public Float

400.84M

Beta

49.06

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

N/A

Yield

N/A

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

PHCRF Performance

No Data Available

PHCRF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About healius - PHCRF

Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Imaging, and Other. The Pathology segment provides pathology services. The Imaging segment focuses on imaging services from stand-alone imaging sites, hospitals, and medical centers. The Other segment consists of corporate functions. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in Sydney, Australia.

PHCRF At a Glance

Healius Ltd.
Liberty Place
Sydney, New South Wales (NSW) 2000
Phone 61-2-9432-9400 Revenue 870.55M
Industry Medical/Nursing Services Net Income -340,912,952.82
Sector Health Services Employees 8,000
Fiscal Year-end 06 / 2026
View SEC Filings

PHCRF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA N/A
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

PHCRF Efficiency

Revenue/Employee 108,818.197
Income Per Employee -42,614.119
Receivables Turnover 8.909
Total Asset Turnover 0.552

PHCRF Liquidity

Current Ratio 0.565
Quick Ratio 0.498
Cash Ratio 0.128

PHCRF Profitability

Gross Margin 16.381
Operating Margin 0.015
Pretax Margin -44.049
Net Margin -39.161
Return on Assets -23.102
Return on Equity -67.502
Return on Total Capital -37.099
Return on Invested Capital -29.825

PHCRF Capital Structure

Total Debt to Total Equity 155.094
Total Debt to Total Capital 60.799
Total Debt to Total Assets 51.311
Long-Term Debt to Equity 124.256
Long-Term Debt to Total Capital 48.71
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Healius - PHCRF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.69B 1.15B 1.14B 870.55M
Sales Growth
+19.49% -32.23% -0.34% -23.92%
Cost of Goods Sold (COGS) incl D&A
1.12B 918.30M 927.63M 727.94M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
201.97M 186.46M 184.27M 145.26M
Depreciation
191.60M 176.03M 174.83M 139.56M
Amortization of Intangibles
10.37M 10.43M 9.44M 5.70M
COGS Growth
+9.41% -18.12% +1.02% -21.53%
Gross Income
572.61M 229.84M 216.64M 142.61M
Gross Income Growth
+45.80% -59.86% -5.75% -34.17%
Gross Profit Margin
+33.80% +20.02% +18.93% +16.38%
2022 2023 2024 2025 5-year trend
SG&A Expense
234.02M 166.01M 173.72M 142.48M
Research & Development
- - - -
-
Other SG&A
234.02M 166.01M 173.72M 142.48M
SGA Growth
+10.23% -29.06% +4.64% -17.98%
Other Operating Expense
- - - (362.60K)
-
Unusual Expense
- 289.17M 422.53M 341.43M
EBIT after Unusual Expense
338.95M (225.34M) (379.61M) (341.30M)
Non Operating Income/Expense
- - - -
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
36.62M 41.91M 46.39M 42.16M
Interest Expense Growth
-11.22% +14.43% +10.71% -9.13%
Gross Interest Expense
36.62M 41.91M 46.39M 42.16M
Interest Capitalized
- - - -
-
Pretax Income
302.33M (267.24M) (426.00M) (383.46M)
Pretax Income Growth
+141.54% -188.39% -59.41% +9.99%
Pretax Margin
+17.85% -23.28% -37.23% -44.05%
Income Tax
89.13M (11.64M) (9.24M) (18.85M)
Income Tax - Current - Domestic
80.06M (672.65K) (11.40M) 64.76K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
9.06M (10.96M) 2.16M (18.91M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
213.21M (255.61M) (416.76M) (364.62M)
Minority Interest Expense
- - - -
-
Net Income
213.21M (255.61M) (416.76M) (364.62M)
Net Income Growth
+331.10% -219.89% -63.05% +12.51%
Net Margin Growth
+12.58% -22.26% -36.42% -41.88%
Extraordinaries & Discontinued Operations
(1.89M) 3.63M (6.42M) 23.70M
Discontinued Operations
(1.89M) 3.63M (6.42M) 23.70M
Net Income After Extraordinaries
211.32M (251.97M) (423.18M) (340.91M)
Preferred Dividends
- - - -
-
Net Income Available to Common
211.32M (251.97M) (423.18M) (340.91M)
EPS (Basic)
0.3352 -0.4093 -0.6414 -0.4695
EPS (Basic) Growth
+477.93% -222.11% -56.71% +26.80%
Basic Shares Outstanding
630.46M 615.57M 659.76M 726.13M
EPS (Diluted)
0.3304 -0.4093 -0.6414 -0.4695
EPS (Diluted) Growth
+476.61% -223.88% -56.71% +26.80%
Diluted Shares Outstanding
639.50M 615.57M 659.76M 726.13M
EBITDA
540.92M 250.29M 227.19M 145.39M
EBITDA Growth
+44.25% -53.73% -9.23% -36.00%
EBITDA Margin
+31.93% +21.80% +19.85% +16.70%

Healius in the News